Marcin Czech (0000-0001-7292-1712)

Personal information

Biography

Marcin Czech is a full professor and head of the Department of Pharmacoeconomics at the Institute of Mother and Child in Warsaw, President of ISPOR, Poland Chapter, course director of postgraduate programmes at the Business School, Warsaw University of Technology, former Vice Minister of Health responsible for medicines policy and international co-operation.
He is the author of over 280 articles and reports in the field of management, health economics, pharmacoeconomics and quality of life, published both in foreign and Polish journals. He promoted over 200 master's and diploma theses, he is a member of working groups, including the Polish Academy of Sciences, editorial boards, and scientific specialist journals, he is a reviewer of research works (also as expert of the National Science Centre, the Agency of Medical Research), PhD theses and books, scientific articles, he participated in the implementation of scientific grants also those financed by the European Union. He worked in international business and advisory environment where he was responsible for health economics and RWE.
A medical doctor by education, specialist in epidemiology and specialist in public health, holding PhD degrees in medicine and management, MBA; completed postgraduate studies in health economics, Leadership Academy, university trainings at the University of York, University of St. Andrews, Mc. Master University, and several certified specialty courses.

Activities

Collapse all

Instytut Matki i Dziecka: Warszawa, PL

2017-05-01 to present | Professor (Pharmacoeconomics)

Employment

Marcin Czech

https://orcid.org/0000-0001-7292-1712

Personal information

Other IDs

Keywords

Countries

Biography

Activities

Employment (3)

Instytut Matki i Dziecka: Warszawa, PL

Warsaw University of Technology: Warsaw, PL

Ministry of Health: Warsaw, PL

Education and qualifications (4)

Institute of Mother and Child: Warsaw, PL

University of Warsaw: Warsaw, PL

Institute of Aviation Medicine: Warsaw, PL

Medical University of Warsaw: Warsaw, Mazovian, PL

Works (50 of 66)

Knowledge and Beliefs about Clinical Trials among Adults in Poland: A Cross-Sectional Study

Facilitators and Barriers of Incremental Innovation by Fixed Dose Combinations in Cardiovascular Diseases

Epidemiology of Respiratory Syncytial Virus Hospitalizations in Poland: An Analysis from 2015 to 2023 Covering the Entire Polish Population of Children Aged under Five Years

Knowledge and Beliefs of Clinical Trials Among Adults in Poland

Are Polish Hospital Pharmacies Ready for Changes in Drug Distribution?

Knowledge and Beliefs of Clinical Trials Among Adults in Poland

Improving Vaccine Assessment Pathways and Decision Making in the Polish Immunization Program

Awareness, Attitudes and Willingness to Donate Biological Samples to a Biobank: A Survey of a Representative Sample of Polish Citizens

Respiratory Syncytial Virus Infections in Polish Pediatric Patients from an Expert Perspective

Awareness, Attitudes and Willingness to Donate Biological Samples to a Biobank: A Survey of a Representative Sample of Polish Citizens

Advancements in diabetes Care in Poland

Real World Evidence on the Effectiveness of Nusinersen within the National Program to Treat Spinal Muscular Atrophy in Poland

Analysis of diabetes-related complications and the cost of diabetes in Poland. The methodology and the research sample used in <i>Economedica DM-PL</i> Survey

Guidance on using real-world evidence from Western Europe in Central and Eastern European health policy decision making

Seasonally Dependent Change of the Number of Fractures after 50 Years of Age in Poland—Analysis of Combined Health Care and Climate Datasets

Impact of COVID-19 Pandemic on the Use of Antidepressant and Antianxiety Pharmaceuticals as Well as Sick Leave in Poland

Applicability of the EVIDEM multi-criteria decision analysis framework for orphan drugs Ñ results from a study in 7 Eurasian countries

Overview of regulatory initiatives in the European Union to stimulate research and accelerate access to orphan drugs and other high medical need products

Prevalence of diabetes in Poland: a combined analysis of national databases

Real-world evidence of patient outcome following treatment of advanced gastrointestinal stromal tumor (GIST) with imatinib, sunitinib, and sorafenib in publicly funded health care in Poland

Reimbursement legislations and decision making for orphan drugs in central and eastern european countries

Bridging east with west of Europe - A comparison of orphan drugs policies in Poland, Russia and the Netherlands

Chronic heart failure management in primary healthcare in Poland: Results of a nationwide cross-sectional study

Multi-Criteria Decision Analysis (MCDA) Models in Health Technology Assessment of Orphan Drugs-a Systematic Literature Review. Next Steps in Methodology Development?

Quality of care of hospitalised patients with heart failure in Poland in 2013: Results of the second nationwide survey

Regional differences in insulin therapy regimens in five European countries

Treatment persistence in the use of basal insulins in Poland and Germany

Cost of severe hypoglycaemia in nine European countries

In-Hospital Mortality in a 4-Year Cohort Study of 3,093,254 Operations in Seniors

Patient’s age rather than severity of the arrhythmia influences the cost of medical treatment of atrioventricular nodal or atrioventricular reciprocating tachycardia

Real-world evidence and Big Data in medicine: Is there a financial and legal risk linked to cyber crime?

Cost of hospitalizations due to microvascular and macrovascular complications in type 1 and type 2 diabetic patients in Bulgaria

Drug-related risk of severe hypoglycaemia in observational studies: A systematic review and meta-analysis

Economic resources consumption structure in severe hypoglycemia episodes: A systematic review and meta-analysis

Evaluation of economic effects of population ageing--methodology of estimating indirect costs

Real-life treatment patterns and medication costs in patients with hypertension treated with ramipril monotherapy or ramipril loose and fixed combinations in Poland

Economic resources consumption structure in severe hypoglycemia episodes: a systematic review and meta-analysis.

Evaluation of economic effects of population ageing--methodology of estimating indirect costs.

Regional differences in diabetic patients' pharmacotherapy in Bulgaria

Risk of severe hypoglycaemia for various treatment regimens – a systematic review and meta-analysis of observational studies

Annual Cost Of Conservative Treatment Of Supraventricular Tachycardias In Poland.

Cost of Severe Hypoglycaemia in Hospitalized Patients In Poland- Is It Financed and Reported in a Right Way?

Regional differences in diabetic patients' pharmacotherapy in Bulgaria.

Antibacterial prescriptions for acute gastrointestinal infections: Uncovering the iceberg

Comparative analysis of the cost of insulin treated patients in Bulgaria

Costs of medically attended acute gastrointestinal infections: The polish prospective healthcare utilization survey

Mortality after surgery in Europe

The costs of heart failure in Poland from the public payer's perspective. Polish programme assessing diagnostic procedures, treatment and costs in patients with heart failure in randomly selected outpatient clinics and hospitals at different levels of care: POLKARD

Methodology and development of the Polish Dictionary of Quality of Life Terms

Cost-effectiveness of biphasic insulin aspart 30 vs. human premix insulin in type 2 diabetes from the payer's perspective in Bulgaria

Peer review (5 reviews for 3 publications/grants)